Collegium Pharma Balance Sheet - Quarterly (NASDAQ:COLL)

Add to My Stocks
$14.2 $0.04 (0.28%) COLL stock closing price Sep 18, 2018 (Closing)

The Collegium Pharma balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Collegium Pharma stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Collegium Pharma had a long term debt of $325.95M at the end of 2018 Q2. To understand the debt servicing capacity of the company, one needs to look at Collegium Pharma operating cash flow and Collegium Pharma revenue also. Collegium Pharma debt to equity ratio is 5.33.

View and download Collegium Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets5.62M5.52M3M4.06M3M2.06M1.9M1.08M1.53M-
Total Current Assets
Property Plant & Equipment--3.49M---2.37M---
Accumulated Depreciation--1.66M---1.33M---
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----5M-----
Accounts Payable18.69M9.33M5.68M4.98M5.61M6.79M9.1M8.97M6.07M6.18M
Current Portion Long-Term Debt114.83M131.05M1.47M2.14M2.38M2.55M2.66M-2.66M2.66M
Current Portion Capital Leases----------
Accrued Expenses131.19M109.83M24.32M19.26M10.19M6.48M8.87M6.63M5.53M2.21M
Income Taxes Payable----------
Other Current Liabilities----10.36M8.69M4.94M6.6M3.92M-
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt325.95M355.22M----1.47M2.14M2.81M3.48M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus412.41M407.49M402.09M376.88M362.86M360.6M358.06M269.92M267.81M266.37M
Retained Earnings-329.76M-316.7M-298.04M-280.64M-267.38M-246.26M-223.18M-195.62M-169.18M-144.66M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity82.68M90.82M104.08M96.26M95.51M114.36M134.9M74.32M98.65M121.73M
Total Liabilities & Shareholders Equity673.33M696.27M135.56M122.67M124.51M139.84M162.01M98.72M119.72M136.34M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Collegium Pharma stock price, and Collegium Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Collegium Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Collegium Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for COLL stock as of 2018 Q2 is $673.33M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Collegium Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for COLL stock stand at $590.65M.

Collegium Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio